UNIGE document Scientific Article
previous document  unige:21446  next document
add to browser collection
Title

The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone
Authors
Martinez De Tejada Weber, Begona
Martillotti Mbo, Gabriella
Lapaire, Olav
Hoesli, Irene
Irion, Olivier
Published in The Journal of Maternal - Fetal & Neonatal Medicine. 2010, vol. 23, no. 9, p. 988-93
Abstract Recent data have raised concern about the safety of using misoprostol in women with preeclampsia. We wanted to evaluate the risk of placental abruption in women with preeclampsia undergoing cervical ripening with misoprostol compared to dinoprostone.
Keywords Abruptio Placentae/epidemiology/etiology — Administration, Intravaginal — Adolescent — Adult — Cervical Ripening/drug effects — Dinoprostone/administration & dosage/adverse effects — Female — Humans — Incidence — Labor, Induced/methods — Middle Aged — Misoprostol/administration & dosage/adverse effects — Oxytocics/administration & dosage/adverse effects — Pre-Eclampsia/epidemiology/therapy — Pregnancy — Prostaglandins/administration & dosage/adverse effects — Risk — Young Adult
Identifiers
PMID: 19941444
Full text
Article (Published version) (186 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique
Research group Martinez De Tejada Begona (272)
Citation
(ISO format) 		MARTINEZ DE TEJADA WEBER, Begona et al. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone. In: Journal of Maternal-Fetal and Neonatal Medicine, 2010, vol. 23, n° 9, p. 988-93. doi: 10.3109/14767050903443475 https://archive-ouverte.unige.ch/unige:21446

532 hits

0 download

Contact an author

Update request

Update

Deposited on : 2012-05-25

Export document
Format :
Citation style :